Emil Kuriakose - 01 Apr 2025 Form 4 Insider Report for Terns Pharmaceuticals, Inc. (TERN)

Role: Chief Medical Officer
Signature: /s/ David Strauss, as Attorney-in-Fact for Emil Kuriakose
Issuer symbol: TERN
Transactions as of: 01 Apr 2025
Net transactions value: -$2,366
Form type: 4
Filing time: 02 Apr 2025, 18:48:56 UTC
Previous filing: 03 Feb 2025
Next filing: 03 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TERN	Common Stock	Sale	$2,366	-952	-1.8%	$2.49	53,317	01 Apr 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.
F2	This sale price represents the weighted average sale price of the shares sold ranging from $2.475 to $2.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

Represents shares of common stock sold to satisfy taxes associated with the vesting of a restricted stock unit award previously granted to the Reporting Person. Such sales do not represent a discretionary trade by the Reporting Person.

This sale price represents the weighted average sale price of the shares sold ranging from $2.475 to $2.54 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.